Intraluminal device, catheter assembly, and method of use thereof

• US 20070027530A1
• Filed: 07/26/2005
• Published: 02/01/2007
• Est. Priority Date: 07/26/2005
• Status: Abandoned Application

• Current Assignee: Medtronic Vascular, Inc. (Medtronic Plc)
• Original Assignee: Medtronic Vascular, Inc. (Medtronic Plc)
• Inventors: Saint, Sean, Nolting, John
• Application Number:
  US11/189,415
• Publication Number:
  US 20070027530A1
• Time in Patent Office: Days
• US Class Current: 623/1.420
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2/958 Inflatable balloons for placing stents or stent-grafts
• CPC Class Codes: A61F 2002/91541 Adjacent bands are arranged out of phase
• CPC Class Codes: A61F 2002/9155 Adjacent bands being connected to each other
• CPC Class Codes: A61F 2230/0013 Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body
• CPC Class Codes: A61F 2250/0068 the pharmaceutical product being in a reservoir

Abstract

An intraluminal device, an intraluminal stent delivery system, and a method of manufacturing the same. The device comprises a body including at least one strut. The strut comprises at least one raised portion positioned on an outer surface of the body. At least one therapeutic agent coating is positioned on the strut. The therapeutic agent coating comprises an effective therapeutic agent coating area greater than about 50 percent of a strut total surface area. The stent delivery system includes a catheter and the stent disposed on the catheter. The manufacturing method includes providing a body including at least one strut. The strut comprises at least one raised portion positioned on an outer surface of the body. At least one therapeutic agent coating is applied on the strut to an effective therapeutic agent coating area greater than about 50 percent of a strut total surface area.

Claims

1. An intraluminal device comprising:

a body including at least one strut, the strut comprising at least one raised portion positioned on an outer surface of the body;

at least one therapeutic agent coating positioned on the strut, the therapeutic agent coating comprising an effective therapeutic agent coating area greater than about 50 percent of a strut total surface area.

2. The device of claim 1 wherein the body is selected from a group consisting of a stent and a graft.

3. The device of claim 1 wherein the strut comprises at least one recessed area formed therein, the at least one recessed area including the therapeutic agent coating positioned therein.

4. The device of claim 1 wherein the strut total surface area comprises the outer surface of the body and an inner surface of the body.

5. The device of claim 1 wherein the at least one strut is substantially encompassed by a vessel endothelium.

6. The device of claim 1 further comprising a sheath including a lumen formed therein for receiving the body.

7. The device of claim 6 wherein the at least one raised portion spaces the outer surface of the body substantially away from a sheath inner surface of the sheath.

8. An intraluminal stent delivery system comprising:

a catheter; and

a stent disposed on the catheter, the stent comprising a body including at least one strut, the strut comprising at least one raised portion positioned on an outer surface of the body;

at least one therapeutic agent coating positioned on the strut, the therapeutic agent coating comprising an effective therapeutic agent coating area greater than about 50 percent of a strut total surface area.

9. The system of claim 8 wherein the strut comprises at least one recessed area formed therein, the at least one recessed area including the therapeutic agent coating positioned therein.

10. The system of claim 8 wherein the strut total surface area comprises the outer surface of the body and an inner surface of the body.

11. The system of claim 8 wherein the at least one strut is substantially encompassed by a vessel endothelium.

12. The system of claim 8 further comprising a sheath including a lumen formed therein for receiving the body.

13. The system of claim 12 wherein the at least one raised portion spaces the outer surface of the body substantially away from a sheath inner surface of the sheath.

14. A method of manufacturing an intraluminal device, the method comprising:

providing a body including at least one strut, the strut comprising at least one raised portion positioned on an outer surface of the body;

applying at least one therapeutic agent coating on the strut to an effective therapeutic agent coating area greater than about 50 percent of a strut total surface area.

15. The method of claim 14 wherein the body is selected from a group consisting of a stent and a graft.

16. The method of claim 14 wherein the at least one therapeutic agent coating is applied to at least one recessed area formed within the strut.

17. The method of claim 14 wherein the strut total surface area comprises the outer surface of the body and an inner surface of the body.

18. The method of claim 14 further comprising substantially encompassing the at least one strut with a vessel endothelium.

19. The method of claim 14 further comprising positioning the body within a lumen formed within a sheath.

20. The method of claim 19 further comprising spacing the outer surface of the body substantially away from a sheath inner surface of the sheath.